You are here

• Home
• Therapy Areas
• Gastrointestinal

• Randomised, double-blind, placebo-controlled multicenter study to assess management strategies in the treatment of Helicobacter pylori infected patients with gastro-oesophageal reflux disease (GERD)

Disease

gastrointestinal diseases

Drug Name

Nexium

Generic Name

esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

IIIa

Start Date

Nov 21, 2003

Study Name

D9612L00201

Study Id

D9612L00201

ClinicalTrials.gov ID

Not Applicable

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 18, 1971

• D9612L00201.pdf (44 KB)

Page tools

• Print
• Bookmark this page